AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 NOV 15 - (NewsRx.com & NewsRx.net) -- Breast cancer is the second most common form of cancer among women in the United States, and the second leading cause of cancer deaths among women. But when detected early, the chances for successful treatment of breast cancer are much improved.
Many women think that with new cancer drugs, such as tamoxifen, breast cancer is not as serious or deadly as it once was. This is a dangerous misconception. Breast cancer kills 138,000 American women each year, and as of yet, there is no foolproof treatment or cure.
Popular breast cancer drug treatments such as tamoxifen work by blocking tumor stimulating properties of estrogen, but sometimes tamoxifen stops working. Tumors that initially respond to the drug by shrinking can become resistant and begin growing again. In some cases, tamoxifen can actually stimulate rather than suppress tumor growth.
National Foundation for Cancer Research scientist Dr. Kathryn B. Horowitz has conducted research to determine what factors cause tamoxifen to stop working or to stimulate rather than suppress tumor growth. Her research is directed toward controlling the ratio of chemical reactions to improve a tumor's inhibitory response to tamoxifen. The outcome of this type of research could mean blocking tumor growth long-term in more women and therefore saving lives that are now being lost.
The National Foundation for Cancer Research is wholly committed to this type of ...
Source: HighBeam Research, Tips For Prevention And Early Detection Published.(Brief Article)